(Q36489794)

14 August 2017

Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy (English)

1 reference

14 August 2017

0 references

anti-retroviral agent

0 references

1 reference

5

Stuart E Starr

1 reference

14 August 2017

Richard C Brundage

1

1 reference

14 August 2017

Florence H Yong

2

1 reference

14 August 2017

Terence Fenton

3

1 reference

14 August 2017

Stephen A Spector

4

1 reference

14 August 2017

Courtney V Fletcher

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Antimicrobial Agents and Chemotherapy

14 August 2017

1 reference

14 August 2017

48

1 reference

14 August 2017

3

1 reference

14 August 2017

979-984

1 reference

Position paper on therapeutic drug monitoring of antiretroviral agents

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353062

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353062

Indinavir concentrations and antiviral effect

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353062

Features of tree-structured survival analysis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353062

Development of normalized curves for the international growth reference: historical and technical considerations.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353062

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353062

Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353062

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353062

Concentration-controlled zidovudine therapy

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14982792

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.48.3.979-984.2004

1 reference

14 August 2017

1 reference

14 August 2017

1 reference